1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34151896 | Cost-effectiveness Analysis of Ado-trastuzumab Emtansine (T-DM1) for the Adjuvant Treatment of Patients With Residual Invasive HER2+ Early Breast Cancer in the United States. | 2021 Jul 1 | 1 |